So sorry to hear all of that! Poor girl!
Clotting issues have been reported with both ITP and splenectomy. Unfortunately, that is one thing that can come along with either or both of those. With ITP, some people have APS (Antiphospholipid Syndrome) which can cause clotting. A few have had to be on blood thinners while having ITP. I have the antibodies, but have never had a clot. Right now, I just take aspirin. People with ITP are also known to have microplatelet particles, which are tiny platelet fragments that cannot be counted. Those can also contribute to clotting. Has she been tested for APS? I read an article once that stated that it's possible the body lowers platelets on purpose to protect against clotting if the APS antibodies are present (see below).
Both APS and microplatelet particles can increase the clotting risk after splenectomy. It can be a tough thing to balance. I hope she levels out soon with a good treatment plan.
Article:
Eleven ITP patients in our study experienced thrombosis (6 patients had venous thromboembolism and 5 had arterial thrombosis). We noticed that thrombotic complications mostly developed after the platelet counts had exceeded 100 × 109/L after methylprednisolone therapy or splenectomy in ITP patients with persistent APA positivity. These data are consistent with the suggestion that severe thrombocytopenia might be a protective factor for the development of thrombosis in APS. Prospective studies are needed to determine whether low-dose aspirin or other drugs have a prophylactic effect on thrombosis in these patients.
In conclusion, we propose that measurement of APAs, especially LA, in patients with an initial diagnosis of ITP may identify a subgroup of patients with a high risk of developing APS features (ie, thrombosis or fetal loss). The episodic nature of the clinical complications of APS, compared with the gradual development of other autoimmune diseases such as SLE, warrants a need for a serologic workup rather than clinical follow-up. A prophylactic drug regimen may avoid the potential complications of APS in patients with ITP and positive LA, considering the high correlation between LA positivity and thrombosis. Future research may determine other markers, including genetic factors, that may help to identify high-risk patients.
www.bloodjournal.org/cgi/content/full/98/6/1760